An ABC of drug-related problems

被引:71
作者
Meyboom, RHB
Lindquist, M
Egberts, ACG
机构
[1] Uppsala Monitoring Ctr, WHO, Collaborating Ctr Int Drug Monitoring, S-75320 Uppsala, Sweden
[2] Netherlands Pharmacovigilance Fdn, LAREB, Shertogenbosch, Netherlands
[3] Univ Utrecht, Fac Pharm, Dept Pharmacoepidemiol & Phamactherapy, Utrecht, Netherlands
[4] TweeSteden Hosp, Tilburg, Netherlands
关键词
D O I
10.2165/00002018-200022060-00001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The problems relating to the use of medicines are manifold. They may differ in pharmacological, pathological, epidemiological and legal respects, and may have different consequences, for example, as regards scientific study, regulation or rational use. Pharmacovigilance is concerned with all such problems: adverse effects and interactions as well as problems relating to ineffectiveness, inappropriate use, counterfeiting, dependence or poisoning. Practically all medicine-related problems can be classified in one basic system, taking into account their characteristics and distinctions. This system distinguishes between appropriate and inappropriate drug use, dose-related problems, and types A ('drug actions'), B ('patient reactions') and C ('statistical') adverse effects. This classification may serve as an educational tool and may be useful in when choosing a study method and for the design of effective strategies in pharmacovigilance.
引用
收藏
页码:415 / 423
页数:9
相关论文
共 21 条
[1]  
[Anonymous], 1996, HOUDINI FX
[2]  
[Anonymous], BR MED J
[3]  
[Anonymous], 1999, ERR HUMAN BUILDING S
[4]  
*COMM ASS BIOM ASP, 1975, JAMA-J AM MED ASSOC, V213, P583
[5]   Survey of unlicensed and off label drug use in paediatric wards in European countries [J].
Conroy, S ;
Choonara, I ;
Impicciatore, P ;
Mohn, A ;
Arnell, H ;
Rane, AR ;
Knoeppel, C ;
Seyberth, H ;
Pandolfini, C ;
Raffaelli, MP ;
Rocchi, F ;
Bonati, M ;
't Jong, G ;
de Hoog, M ;
van den Anker, J .
BRITISH MEDICAL JOURNAL, 2000, 320 (7227) :79-82
[6]   Analgesic nephropathy [J].
De Broe, ME ;
Elseviers, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :446-452
[7]   HARMONIZATION IN PHARMACOVIGILANCE [J].
EDWARDS, IR ;
BIRIELL, C .
DRUG SAFETY, 1994, 10 (02) :93-102
[8]  
Imbs JL, 1999, THERAPIE, V54, P21
[9]  
Inman WHW, 1986, MONITORING DRUG SAFE
[10]  
KIMURA K, 1998, WHO DATA BASE COUNTE